You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中新藥業(600329.SH):津滬深公司間接控股公司、津滬深公司無實控人
格隆匯 03-28 15:20

格隆匯 3 月 28日丨中新藥業(600329.SH)公佈,公司控股股東天津市醫藥集團有限公司(“醫藥集團”)開展國有企業混合所有制改革。公司2021326收到醫藥集團關於混合所有制改革進展的通知截至公吿披露日,醫藥集團持有公司42.80%

公司於2021326日獲悉醫藥集團混合所有制改革取得進展,相關情況如下:

醫藥集團67%股權公開掛牌轉讓項目的最終受讓方為津滬深生物醫藥科技有限公司(“津滬深公司”)。依據《產權交易合同》約定,津滬深公司已於近日支付了全部股權轉讓價款,且天津產權交易中心已出具本次交易《國有產權交易憑證》。

2021326日,醫藥集團已完成此次股權轉讓工商變更登記手續。醫藥集團由天津渤海國有資產經營管理有限公司(“渤海國資”)100%控股變為津滬深公司持股67%、渤海國資持股33%

次變動後,天津市人民政府國有資產監督管理委員會不再為公司實際控制人,公司控股股東醫藥集團及其持股數量不變,津滬深公司間接控股公司;津滬深公司無實際控制人。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account